Excess all‐cause and cause‐specific mortality for people with diabetes and end‐stage kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Excess all‐cause and cause‐specific mortality for people with diabetes and end‐stage kidney disease

Published:2021-12-29 Issue: Volume: Page:
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet Med

Author:

Morton Jedidiah I.¹²^ORCID,Sacre Julian W.¹^ORCID,McDonald Stephen P.³⁴,Magliano Dianna J.¹²,Shaw Jonathan E.¹²

Affiliation:

1. Baker Heart and Diabetes Institute Melbourne Victoria Australia

2. School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia

3. Australia and New Zealand Dialysis and Transplant Registry South Australia Health and Medical Research Institute Adelaide Australia

4. Adelaide Medical School University of Adelaide Adelaide Australia

Funder

National Health and Medical Research Council

Australian Government

State Government of Victoria

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14775

Reference31 articles.

1. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

2. Data from the ERA-EDTA Registry were examined for trends in excess mortality in European adults on kidney replacement therapy

3. Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013

4. Secular Trends in Cardiovascular Mortality Rates of Patients Receiving Dialysis Compared With the General Population

5. Effect of type 2 diabetes on mortality risk associated with end‐stage kidney disease;Villar E;Diabetologia,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia;American Journal of Kidney Diseases;2024-01

2. Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes;Cells;2022-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3